Concepedia

Johannes Weirather

JW

18

Publications

2.5K

Citations

16

H-Index

2012

Active since

Affiliations

MorphoSys (Germany)(Current)

University of Würzburg

Universitätsklinikum Würzburg

Semmelweis University

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

Johannes Weirather is an author at MorphoSys (Germany) specializing in immunology, medicine, and radiation oncology.

Top concepts

Publications per year

2012–2024

18

Publications

18

Foxp3<sup>+</sup>CD4<sup>+</sup>T Cells Improve Healing After Myocardial Infarction by Modulating Monocyte/Macrophage Differentiation

Johannes Weirather, Ulrich Hofmann, Niklas Beyersdorf et al. · Circulation Research · 2014 · 691 citations · Full text

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

Gilles Salles, Johannes Duell, Eva González‐Barca et al. · The Lancet Oncology · 2020 · 504 citations · Full text

, , +5

Activation of CD4 <sup>+</sup> T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice

Ulrich Hofmann, Niklas Beyersdorf, Johannes Weirather et al. · Circulation · 2012 · 462 citations · Full text

Myocardial aging as a T-cell–mediated phenomenon

Gustavo C. Ramos, Anne van den Berg, Vânia Silva et al. · Proceedings of the National Academy of Sciences · 2017 · 163 citations · Full text

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

Johannes Duell, Kami J. Maddocks, Eva González‐Barca et al. · Haematologica · 2021 · 134 citations · Full text

, , +7

Rows per page

1–5 of 18